This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: The Innovative Work of Nada Kosutic Hulita
Introduction
Nada Kosutic Hulita is a prominent inventor based in Zagreb, Croatia, known for her significant contributions to the pharmaceutical industry. With two patents to her name, her work centers on the development of solid-state forms of sitagliptin salts, which play a crucial role in treating type 2 diabetes mellitus.
Latest Patents
Nada's latest patents include innovative formulations of sitagliptin salts, specifically focusing on solid-state forms and their crystalline counterparts. The first patent details solid-state forms of sitagliptin, including sitagliptin sulfate, along with processes for their preparation and pharmaceutical compositions. The second patent addresses the creation of crystalline forms of sitagliptin salts and outlines the methods for preparing them, further enhancing their applications in medicinal products.
Career Highlights
Nada Kosutic Hulita is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. Her expertise in the formulation of pharmaceutical compounds has made her an invaluable asset to her organization.
Collaborations
Throughout her career, Nada has collaborated with notable colleagues such as Nurit Perlman and Ariel Mittelman, contributing to innovations that benefit the medical community and improve patient outcomes.
Conclusion
With her pioneering work and significant patents, Nada Kosutic Hulita continues to make remarkable strides in the field of pharmaceutical innovations, particularly in the management of type 2 diabetes mellitus. Her dedication to advancing medical science exemplifies the impact of inventors in enhancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
